Radiolife Co.

The Purpose of This Agreement Is to Develop and Validate a Groundbreaking, Reagent-less Diagnostic Device (cube Scan) Leveraging Radio Frequency (RF) and Artificial Intelligence (AI) Technology for the Rapid and Accurate Detection of Highly Pathogenic Avian Influenza (HPAI) in Poultry. This Initiative Aims to Transform Hpai Diagnostics by Providing a Cost-effective, Field-deployable Solution Capable of Delivering Immediate, Accurate Results Without the Need for Reagents. to Achieve These Objectives, the Project Will Involve Comprehensive Activities, Including Extensive Sample Collection, Ai Model Refinement, Device Optimization, and Multi-site Field Testing. Radiolife Will Train Cube Scan’s Ai to Recognize RF Signatures of Hpai, Validate Its Diagnostic Accuracy, and Assess Its Performance in Real-world Settings. the Goal Is to Improve Response Strategies, Enhance Biosecurity, and Mitigate Economic Losses for Poultry Producers, Veterinary Laboratories, and Regulatory Agencies.